Pediatric care platform - instant pediatrician support with a dedicated team of doctors for each parenting stage. 100 doctors onboard with pediatrician support at ₹1,000-2,000 a month and programs like sleep training at ₹2,500-5,000 a month. $700K seed round. Other investors in this round: Amplify, Abhishek Sharma (Fashinza), Ankit Gupta (Bicycle Health), Akshay Saxena (Avanti), Dhruv Dhanraj Bahl (Eternal Capital).

Autonomous AI agents to help doctors with disease diagnosis, treatment and prognosis. Jaipur based. ₹3CR pre-seed round. Angels in the round: Dr. Rohan Khandelwal, Pawan Gupta.

"SVAS": breath, "TEK": technology. Innovative Non Invasive Ventilation (NIV) Mask for hospital use, which allows for continuous non-invasive ventilation while simultaneously administering nutrition to patients. Improves nutrition, reduces recovery times and reduces ventilator usage. ₹2CR raised in this seed round.

Digital platform providing treatment for male reproductive health issues. Each patient is assigned a doctor and personal concierge for personalised treatment covering medication, nutrition, diagnostics, exercises and tech-enabled compliance. The Hindi-medium platform started out in UP and Bihar. ₹7.7CR pre-seed round. Angels: Altaf Saiyed (Traya), Raymond Russell (Pharos Fund), Vaibhav Domkundwar (Better Capital), Shreyas Kumar (Fermat Commerce), Bhargav Tarpara (Greenlit).

Omni-channel generic drugs chain selling products under its own name. Has a network of 225 franchisees and processes 1,500 orders a day online. Building out 60 minute delivery. Zee Laboratories, the founder's family business, is a generic drugs manufacturer which exports to over 50 countries and has 500 distributors in India. It supplies a portion of Zeelab Pharmacy's drugs as a contract manufacturer. $2.4M raised in this seed round.

Diagnostics solutions startup with a range of products to tackle Chronic Kidney Disease (CKD), diabetes and preeclampsia (a pregnancy complication). Proflo-U measures albumin and creatinine round the clock; Eyera Sense allows for high efficiency processing of fluid samples; while Embargo offers a portfolio of DNA and RNA based diagnostics kits. Bhubaneswar based. ₹3CR raised in this seed round.

BioTech startup which uses nanotechnology to target cancer stem cells while sparing healthy cells, thereby reducing the need for chemotherapy and reducing relapse. The company uses exosome-based drug delivery. Exosomes are small sacs that are naturally released by cells and can carry a variety of molecules. Exosomes can be used to transport drugs to specific cells or tissues. The company will manufacture its products inhouse. Bhubaneswar based. ₹3CR raised in this seed round.

Neuroscience startup which enables greater precision in the diagnosis and treatment planning of neuro-oncological and neuropsychiatric disorders. Provides clinicians an fMRI processing engine and machine-learning models; and a patient care app. In India, now looking at US market entry. $5M raised in this Pre-Series A round, with $925K raised earlier from Pfizer.

Gen-AI driven SaaS to manage healthcare insurance claims. Targeting a global customer base. Claims generation, processing and fraud detection, along with a suite of other solutions for hospitals and insurers. ₹5CR raised in this seed round.

AI agents to reduce administrative tasks faced by healthcare providers in the US, a lot of which continue to be manual processes faced by both the providers as well as their patients. Confido part automates tasks such as appointments, payments and pre and post operative engagement. $3M raised in this seed round.